The Leishmania donovani Lipophosphoglycan Excludes the Vesicular Proton-ATPase from Phagosomes by Impairing the Recruitment of Synaptotagmin V

We recently showed that the exocytosis regulator Synaptotagmin (Syt) V is recruited to the nascent phagosome and remains associated throughout the maturation process. In this study, we investigated the possibility that Syt V plays a role in regulating interactions between the phagosome and the endocytic organelles. Silencing of Syt V by RNA interference revealed that Syt V contributes to phagolysosome biogenesis by regulating the acquisition of cathepsin D and the vesicular proton-ATPase. In contrast, recruitment of cathepsin B, the early endosomal marker EEA1 and the lysosomal marker LAMP1 to phagosomes was normal in the absence of Syt V. As Leishmania donovani promastigotes inhibit phagosome maturation, we investigated their potential impact on the phagosomal association of Syt V. This inhibition of phagolysosome biogenesis is mediated by the virulence glycolipid lipophosphoglycan, a polymer of the repeating Galβ1,4Manα1-PO4 units attached to the promastigote surface via an unusual glycosylphosphatidylinositol anchor. Our results showed that insertion of lipophosphoglycan into ganglioside GM1-containing microdomains excluded or caused dissociation of Syt V from phagosome membranes. As a consequence, L. donovani promatigotes established infection in a phagosome from which the vesicular proton-ATPase was excluded and which failed to acidify. Collectively, these results reveal a novel function for Syt V in phagolysosome biogenesis and provide novel insight into the mechanism of vesicular proton-ATPase recruitment to maturing phagosomes. We also provide novel findings into the mechanism of Leishmania pathogenesis, whereby targeting of Syt V is part of the strategy used by L. donovani promastigotes to prevent phagosome acidification

Multi-objective optimization framework to obtain model-based guidelines for tuning biological synthetic devices: an adaptive network case

Background: Model based design plays a fundamental role in synthetic biology. Exploiting modularity, i.e. using biological parts and interconnecting them to build new and more complex biological circuits is one of the key issues. In this context, mathematical models have been used to generate predictions of the behavior of the designed device. Designers not only want the ability to predict the circuit behavior once all its components have been determined, but also to help on the design and selection of its biological parts, i.e. to provide guidelines for the experimental implementation. This is tantamount to obtaining proper values of the model parameters, for the circuit behavior results from the interplay between model structure and parameters tuning. However, determining crisp values for parameters of the involved parts is not a realistic approach. Uncertainty is ubiquitous to biology, and the characterization of biological parts is not exempt from it. Moreover, the desired dynamical behavior for the designed circuit usually results from a trade-off among several goals to be optimized. Results: We propose the use of a multi-objective optimization tuning framework to get a model-based set of guidelines for the selection of the kinetic parameters required to build a biological device with desired behavior. The design criteria are encoded in the formulation of the objectives and optimization problem itself. As a result, on the one hand the designer obtains qualitative regions/intervals of values of the circuit parameters giving rise to the predefined circuit behavior; on the other hand, he obtains useful information for its guidance in the implementation process. These parameters are chosen so that they can effectively be tuned at the wet-lab, i.e. they are effective biological tuning knobs. To show the proposed approach, the methodology is applied to the design of a well known biological circuit: a genetic incoherent feed-forward circuit showing adaptive behavior. Conclusion: The proposed multi-objective optimization design framework is able to provide effective guidelines to tune biological parameters so as to achieve a desired circuit behavior. Moreover, it is easy to analyze the impact of the context on the synthetic device to be designed. That is, one can analyze how the presence of a downstream load influences the performance of the designed circuit, and take it into account.Research in this area is partially supported by Spanish government and European Union (FEDER-CICYT DPI2011-28112-C04-01, and DPI2014-55276-C5-1-R). Yadira Boada thanks grant FPI/2013-3242 of Universitat Politecnica de Valencia; Gilberto Reynoso-Meza gratefully acknowledges the partial support provided by the postdoctoral fellowship BJT-304804/2014-2 from the National Council of Scientific and Technologic Development of Brazil (CNPq) for the development of this work. We are grateful to Alejandra Gonzalez-Bosca for her collaboration on this topic while doing her Bachelor thesis, and to Dr. Jose Luis Pitarch from Universidad de Valladolid for his advise in algorithmic implementations and for proof reading the manuscript.Boada Acosta, YF.; Reynoso Meza, G.; Picó Marco, JA.; Vignoni, A. (2016). Multi-objective optimization framework to obtain model-based guidelines for tuning biological synthetic devices: an adaptive network case. BMC Systems Biology. 10:1-19. https://doi.org/10.1186/s12918-016-0269-0S11910ERASynBio. Next steps for european synthetic biology: a strategic vision from erasynbio. Report, ERASynBio. 2014. https://www.erasynbio.eu/lw_resource/datapool/_items/item_58/erasynbiostrategicvision.pdf .Way J, Collins J, Keasling J, Silver P. Integrating biological redesign: Where synthetic biology came from and where it needs to go. Cell. 2014; 157(1):151–61.Canton B, Labno A, Endy D. Refinement and standardization of synthetic biological parts and devices. Nat Biotechnol. 2008; 26(7):787–93.De Lorenzo V, Danchin A. Synthetic biology: discovering new worlds and new words. EMBO Rep. 2008; 9(9):822–7.Church GM, Elowitz MB, Smolke CD, Voigt CA, Weiss R. Realizing the potential of synthetic biology. Nat Rev Mol Cell Biol. 2014; 15(4):289–94.Takahashi CN, Miller AW, Ekness F, Dunham MJ, Klavins E. A low cost, customizable turbidostat for use in synthetic circuit characterization. ACS Synth Biol. 2015; 4(1):32–8. [doi: 10.1021/sb500165g ].Cooling MT, Rouilly V, Misirli G, Lawson J, Yu T, Hallinan J, Wipat A. Standard virtual biological parts: a repository of modular modeling components for synthetic biology. Bioinformatics. 2010; 26(7):925–31.Medema MH, van Raaphorst R, Takano E, Breitling R. Computational tools for the synthetic design of biochemical pathways. Nat Rev Microbiol. 2012; 10(3):191–202.Marchisio MA, Stelling J. Automatic design of digital synthetic gene circuits. PLoS Comput Biol. 2011; 7(2):e1001083. [doi: 10.1371/journal.pcbi.1001083 ].Rodrigo G, Carrera J, Landrain TE, Jaramillo A. Perspectives on the automatic design of regulatory systems for synthetic biology. FEBS Lett. 2012; 586(15):2037–42.Crook N, Alper HS. Model-based design of synthetic, biological systems. Chem Eng Sci. 2013; 103:2–11.Jayanthi S, Nilgiriwala K, Del Vecchio D. Retroactivity controls the temporal dynamics of gene transcription. ACS Synth Biol. 2013; 2(8):431–41.Mélykúti B, Hespanha JP, Khammash M. Equilibrium distributions of simple biochemical reaction systems for time-scale separation in stochastic reaction networks. J R Soc Interface. 2014; 11(97):20140054.Oyarzún DA, Lugagne JB, Stan GB. Noise propagation in synthetic gene circuits for metabolic control. ACS Synth Biol. 2015; 4(2):116–25. [doi: 10.1021/sb400126a ].Picó J, Vignoni A, Picó-Marco E, Boada Y. Modelado de sistemas bioquímicos: De la ley de acción de masas a la aproximación lineal del ruido. Revista Iberoamericana de Automática e Informática Industrial RIAI. 2015; 12(3):241–52.Feng X-j-J, Hooshangi S, Chen D, Li G, Weiss R, Rabitz H. Optimizing genetic circuits by global sensitivity analysis. Biophys J. 2004; 87(4):2195–202.Dasika MS, Maranas CD. Optcircuit: An optimization based method for computational design of genetic circuits. BMC Syst Biol. 2008; 2:24.Rodrigo G, Carrera J, Jaramillo A. Genetdes. Bioinformatics. 2007; 23(14):1857–8.Otero-Muras I, Banga JR. Multicriteria global optimization for biocircuit design. 2014. arXiv preprint arXiv:1402.7323.Banga JR. Optimization in computational systems biology. BMC Syst Biol. 2008; 2:47.Sendin J, Exler O, Banga JR. Multi-objective mixed integer strategy for the optimisation of biological networks. IET Syst Biol. 2010; 4(3):236–48.Miller M, Hafner M, Sontag E, Davidsohn N, Subramanian S, Purnick PE, Lauffenburger D, Weiss R. Modular design of artificial tissue homeostasis: robust control through synthetic cellular heterogeneity. PLoS Comput Biol. 2012; 8(7):1002579.Ellis T, Wang X, Collins JJ. Diversity-based, model-guided construction of synthetic gene networks with predicted functions. Nat Biotechnol. 2009; 27(5):465–71.Koeppl H, Hafner M, Lu J. Mapping behavioral specifications to model parameters in synthetic biology. BMC Bioinforma. 2013; 14(Suppl 10):9.Chiang AWT, Hwang M-JJ. A computational pipeline for identifying kinetic motifs to aid in the design and improvement of synthetic gene circuits. BMC Bioinforma. 2013; 14 Suppl 16:5.Ma W, Trusina A, El-Samad H, Lim WA, Tang C. Defining network topologies that can achieve biochemical adaptation. Cell. 2009; 138(4):760–73.Chiang AWT, Liu W-CC, Charusanti P, Hwang M-JJ. Understanding system dynamics of an adaptive enzyme network from globally profiled kinetic parameters. BMC Syst Biol. 2014; 8:4.Reynoso-Meza G, Blasco X, Sanchis J, Martínez M. Controller tuning using evolutionary multi-objective optimisation: current trends and applications. Control Eng Pract. 2014; 28:58–73.Alon U. An Introduction To Systems Biology. Design Principles of Biological Circuits. London: Chapman & Hall/ CRC Mathematical and computational Biology Series; 2006.Elowitz MB, Leibler S. A synthetic oscillatory network of transcriptional regulators. Nature. 2000; 403(6767):335–8.Hsiao V, de los Santos ELC, Whitaker WR, Dueber JE, Murray RM. Design and implementation of a biomolecular concentration tracker. ACS Synth Biol. 2015; 4(2):150–61. [doi: 10.1021/sb500024b ].Franco E, Giordano G, Forsberg P-O, Murray RM. Negative autoregulation matches production and demand in synthetic transcriptional networks. ACS Synth Biol. 2014; 3(8):589–99. [doi: 10.1021/sb400157z ].Strelkowa N, Barahona M. Switchable genetic oscillator operating in quasi-stable mode. J R Soc Interface. 2010; 7(48):1071–82.Basu S, Mehreja R, Thiberge S, Chen MT, Weiss R. Spatiotemporal control of gene expression with pulse-generating networks. Proc Natl Acad Sci U S A. 2004; 101(17):6355–60.Bleris L, Xie Z, Glass D, Adadey A, Sontag E, Benenson Y. Synthetic incoherent feedforward circuits show adaptation to the amount of their genetic template. Mol Syst Biol. 2011; 7(519):1–12. [doi: 10.1038/msb.2011.49 ].Hart Y, Antebi YE, Mayo AE, Friedman N, Alon U. Design principles of cell circuits with paradoxical components. Proc Natl Acad Sci. 2012; 109(21):8346–51.Zhang Q, Bhattacharya S, Andersen ME. Ultrasensitive response motifs: basic amplifiers in molecular signalling networks. Open Biol. 2013; 3(4):130031.Weber M, Buceta J, Others. Dynamics of the quorum sensing switch: stochastic and non-stationary effects. BMC Syst Biol. 2013; 7(1):6.Womelsdorf T, Valiante TA, Sahin NT, Miller KJ, Tiesinga P. Dynamic circuit motifs underlying rhythmic gain control, gating and integration. Nat Neurosci. 2014; 17(8):1031–9.Arpino JAJ, Hancock EJ, Anderson J, Barahona M, Stan G-BVB, Papachristodoulou A, Polizzi K. Tuning the dials of synthetic biology. Microbiology. 2013; 159(Pt 7):1236–53.Zagaris A, Kaper HGG, Kaper TJJ. Analysis of the computational singular perturbation reduction method for chemical kinetics. J Nonlinear Sci. 2004; 14(1):59–91.Anderson J, Chang Y-C-C, Papachristodoulou A. Model decomposition and reduction tools for large-scale networks in systems biology. Automatica. 2011; 47(6):1165–74.Prescott TP, Papachristodoulou A. Layered decomposition for the model order reduction of timescale separated biochemical reaction networks. J Theor Biol. 2014; 356:113–22.Hancock EJ, Stan GB, Arpino JAJ, Papachristodoulou A. Simplified mechanistic models of gene regulation for analysis and design. J R Soc Interface. 2015; 12(108).Miettinen K, Vol. 12. Nonlinear Multiobjective Optimization. Boston: Kluwer Academic Publishers; 1999.Miettinen K, Ruiz F, Wierzbicki AP. Introduction to multiobjective optimization: interactive approaches. In: Multiobjective Optimization. Berlin: Springer: 2008. p. 27–57.Deb K, Bandaru S, Greiner D, Gaspar-Cunha A, Tutum CC. An integrated approach to automated innovization for discovering useful design principles: Case studies from engineering. Appl Soft Comput. 2014; 15(0):42–56.Ang J, Ingalls B, McMillen D. Probing the input-output behavior of biochemical and genetic systems: System identification methods from control theory In: Johnson ML, Brand L, editors. Methods in Enzymology. Academic Press: 2011. p. 279–317, doi: 10.1016/B978-0-12-381270-4.00010-X .Mattson CA, Messac A. Pareto frontier based concept selection under uncertainty, with visualization. Optim Eng. 2005; 6(1):85–115.Reynoso-Meza G, Sanchis J, Blasco X, Martínez M. Design of continuous controllers using a multiobjective differential evolution algorithm with spherical pruning. Appl Evol Comput. 2010;532–541.Reynoso-Meza G, García-Nieto S, Sanchis J, Blasco X. Controller tuning using multiobjective optimization algorithms: a global tuning framework. IEEE Trans Control Syst Technol. 2013; 21(2):445–58.Reynoso-Meza G, Sanchis J, Blasco X, Herrero JM. Multiobjective evolutionary algortihms for multivariable PI controller tuning. Expert Syst Appl. 2012; 39:7895–907.Anderson C. Anderson promoter collection [online]. 2006. http://parts.igem.org/Promoters/Catalog/Anderson . Accesed 20 Feb 2015.Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol. 2009; 27(10):946–50.Egbert RG, Klavins E. Fine-tuning gene networks using simple sequence repeats. PNAS. 2012; 109(42):16817–22. [doi: 10.1073/pnas.1205693109 ].Hair JF, Suárez MG. Análisis Multivariante vol. 491. Madrid: Prentice Hall; 1999.Blasco X, Herrero JM, Sanchis J, Martínez M. A new graphical visualization of n-dimensional pareto front for decision-making in multiobjective optimization. Inf Sci. 2008; 178(20):3908–24. [doi: 10.1016/j.ins.2008.06.010 ].Reynoso-Meza G, Blasco X, Sanchis J, Herrero JM. Comparison of design concepts in multi-criteria decision-making using level diagrams. Inform Sci. 2013; 221:124–41.Goentoro L, Shoval O, Kirschner MW, Alon U. The incoherent feedforward loop can provide fold-change detection in gene regulation. Mol Cell. 2009; 36(5):894–9.Rodrigo G, Elena SF. Structural discrimination of robustness in transcriptional feedforward loops for pattern formation. PloS ONE. 2011; 6(2):16904.Kim J, Khetarpal I, Sen S, Murray RM. Synthetic circuit for exact adaptation and fold-change detection. Nucleic Acids Res. 2014; 42(2):6078–89. [doi: 10.1093/nar/gku233 ].Chelliah V, Juty N, Ajmera I, Ali R, Dumousseau M, Glont M, Hucka M, Jalowicki G, Keating S, Knight-Schrijver V, et al. Biomodels: ten-year anniversary. Nucleic Acids Res. 2015; 43(D1):542–8.Ang J, Bagh S, Ingalls BP, McMillen DR. Considerations for using integral feedback control to construct a perfectly adapting synthetic gene network. J Theor Biol. 2010; 266(4):723–38.Biobrick Foundation. 2006. Part Registry [online]. http://partsregistry.org/ . Accessed 20 Feb 2015.BIOSS. 2006. BIOSS Toolbox [online]. http://www.bioss.uni-freiburg.de/cms/toolbox-home.html . Accessed 20 Feb 2015.BioFab. 2006. International Open Facility Advancing Biotechnology [online]. http://www.biofab.org/ . Accessed 20 Feb 2015.Vallerio M, Hufkens J, Van Impe J, Logist F. An interactive decision-support system for multi-objective optimization of nonlinear dynamic processes with uncertainty. Expert Syst Appl. 2015; 42(21):7710–31.Frangopol DM, Maute K. Life-cycle reliability-based optimization of civil and aerospace structures. Comput Struct. 2003; 81(7):397–410.Lozano M, Molina D, Herrera F. Editorial scalability of evolutionary algorithms and other metaheuristics for large-scale continuous optimization problems. Soft Comput. 2011; 15(11):2085–7.Santana-Quintero LV, Montano AA, Coello CAC. A review of techniques for handling expensive functions in evolutionary multi-objective optimization. In: Computational Intelligence in Expensive Optimization Problems. Berlin: Springer: 2010. p. 29–59

Discovery of Markers of Exposure Specific to Bites of Lutzomyia longipalpis, the Vector of Leishmania infantum chagasi in Latin America

Leishmania parasites are transmitted by the bite of an infected vector sand fly that injects salivary molecules into the host skin during feeding. Certain salivary molecules can produce antibodies and can be used as an indicator of exposure to a vector sand fly and potentially the disease it transmits. Here we identified potential markers of specific exposure to the sand fly Lutzomyia longipalpis, the vector of visceral leishmaniasis in Latin America. Initially, we determined which of the salivary proteins produce antibodies in humans, dogs, and foxes from areas endemic for the disease. To identify potential specific markers of vector exposure, we produced nine different recombinant salivary proteins from Lu. longipalpis and tested for their recognition by individuals exposed to another human-biting sand fly, Lu. intermedia, that transmits cutaneous leishmaniasis and commonly occurs in the same endemic areas as Lu. longipalpis. Two of the nine salivary proteins were recognized only by humans exposed to Lu. longipalpis, suggesting they are immunogenic proteins and may be useful in epidemiological studies. The identification of specific salivary proteins as potential markers of exposure to vector sand flies will increase our understanding of vector–human interaction, bring new insights to vector control, and in some instances act as an indicator for risk of acquiring disease

Genome Sequence of Brucella abortus Vaccine Strain S19 Compared to Virulent Strains Yields Candidate Virulence Genes

The Brucella abortus strain S19, a spontaneously attenuated strain, has been used as a vaccine strain in vaccination of cattle against brucellosis for six decades. Despite many studies, the physiological and molecular mechanisms causing the attenuation are not known. We have applied pyrosequencing technology together with conventional sequencing to rapidly and comprehensively determine the complete genome sequence of the attenuated Brucella abortus vaccine strain S19. The main goal of this study is to identify candidate virulence genes by systematic comparative analysis of the attenuated strain with the published genome sequences of two virulent and closely related strains of B. abortus, 9–941 and 2308. The two S19 chromosomes are 2,122,487 and 1,161,449 bp in length. A total of 3062 genes were identified and annotated. Pairwise and reciprocal genome comparisons resulted in a total of 263 genes that were non-identical between the S19 genome and any of the two virulent strains. Amongst these, 45 genes were consistently different between the attenuated strain and the two virulent strains but were identical amongst the virulent strains, which included only two of the 236 genes that have been implicated as virulence factors in literature. The functional analyses of the differences have revealed a total of 24 genes that may be associated with the loss of virulence in S19. Of particular relevance are four genes with more than 60bp consistent difference in S19 compared to both the virulent strains, which, in the virulent strains, encode an outer membrane protein and three proteins involved in erythritol uptake or metabolism

Neurodevelopment of children exposed in utero to treatment of maternal malignancy

Cancer is the second most common cause of death during the reproductive years, complicating approximately 1/1000 pregnancies. The occurrence of cancer during gestation is likely to increase as a result of a woman's tendency to delay childbearing. Improved diagnostic techniques for malignancies increases detection of cancer during pregnancy. Malignant conditions during gestation are believed to be associated with an increase in poor perinatal and fetal outcomes that are often due to maternal treatment. Physicians should weigh the benefits of treatment against the risks of fetal exposure. To date, most reports have focused on morphologic observations made very close to the time of delivery with little data collected on children's long-term neurodevelopment following in utero exposure to malignancy and treatment. Because the brain differentiates throughout pregnancy and in early postnatal life, damage may occur even after first trimester exposure. The possible delayed effects of treatment on a child's neurological, intellectual and behavioural functioning have never been systematically evaluated. The goal of this report was to summarize all related issues into one review to facilitate both practitioners' and patients' access to known data on fetal risks and safety. © 2001 Cancer Research Campaign http://www.bjcancer.co

Genome Degradation in Brucella ovis Corresponds with Narrowing of Its Host Range and Tissue Tropism

Brucella ovis is a veterinary pathogen associated with epididymitis in sheep. Despite its genetic similarity to the zoonotic pathogens B. abortus, B. melitensis and B. suis, B. ovis does not cause zoonotic disease. Genomic analysis of the type strain ATCC25840 revealed a high percentage of pseudogenes and increased numbers of transposable elements compared to the zoonotic Brucella species, suggesting that genome degradation has occurred concomitant with narrowing of the host range of B. ovis. The absence of genomic island 2, encoding functions required for lipopolysaccharide biosynthesis, as well as inactivation of genes encoding urease, nutrient uptake and utilization, and outer membrane proteins may be factors contributing to the avirulence of B. ovis for humans. A 26.5 kb region of B. ovis ATCC25840 Chromosome II was absent from all the sequenced human pathogenic Brucella genomes, but was present in all of 17 B. ovis isolates tested and in three B. ceti isolates, suggesting that this DNA region may be of use for differentiating B. ovis from other Brucella spp. This is the first genomic analysis of a non-zoonotic Brucella species. The results suggest that inactivation of genes involved in nutrient acquisition and utilization, cell envelope structure and urease may have played a role in narrowing of the tissue tropism and host range of B. ovis

Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

\ua9 2023, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. Although over 90 independent risk variants have been identified for Parkinson’s disease using genome-wide association studies, most studies have been performed in just one population at a time. Here we performed a large-scale multi-ancestry meta-analysis of Parkinson’s disease with 49,049 cases, 18,785 proxy cases and 2,458,063 controls including individuals of European, East Asian, Latin American and African ancestry. In a meta-analysis, we identified 78 independent genome-wide significant loci, including 12 potentially novel loci (MTF2, PIK3CA, ADD1, SYBU, IRS2, USP8, PIGL, FASN, MYLK2, USP25, EP300 and PPP6R2) and fine-mapped 6 putative causal variants at 6 known PD loci. By combining our results with publicly available eQTL data, we identified 25 putative risk genes in these novel loci whose expression is associated with PD risk. This work lays the groundwork for future efforts aimed at identifying PD loci in non-European populations